https://axolbio.com/society-for-laboratory-automation-and-screening-slas-2018/ 2022-04-18T18:35:04+00:00 https://axolbio.com/wp-content/uploads/2022/03/service-inner-banner.jpeg https://axolbio.com/axol-bioscience-and-censo-biotechnologies-announce-merger/ 2022-04-18T18:41:49+00:00 https://axolbio.com/wp-content/uploads/2022/03/service-inner-banner.jpeg https://axolbio.com/axol-travel-grant-recipient-european-chapter-meeting-of-the-tissue-engineering-and-regenerative-medicine-international-society-2017/ 2022-05-16T12:44:30+00:00 https://axolbio.com/wp-content/uploads/2022/03/blog-banner.jpeg https://axolbio.com/axol-bioscience-appoints-steve-finkbeiner-as-scientific-advisory-board-member/ 2022-05-16T12:44:35+00:00 https://axolbio.com/wp-content/uploads/2022/03/services-banner.jpeg https://axolbio.com/axol-bioscience-appoints-chief-business-officer/ 2022-05-16T12:45:24+00:00 https://axolbio.com/wp-content/uploads/2022/03/service-image02.jpeg https://axolbio.com/axol-bioscience-is-a-key-participant-in-the-european-unions-horizon-2020-research-programme/ 2022-05-16T12:46:26+00:00 https://axolbio.com/wp-content/uploads/2022/03/3Z0A4583.jpg https://axolbio.com/axol-bioscience-appoints-liam-taylor-as-chief-executive-officer/ 2022-05-16T12:52:17+00:00 https://axolbio.com/wp-content/uploads/2022/04/Stem-Cell-Differentiation.jpeg https://axolbio.com/major-success-for-meso-brain-partners-will-lead-to-breakthrough-technology-for-developing-new-brain-models/ 2022-05-16T12:52:34+00:00 https://axolbio.com/wp-content/uploads/2022/03/element04.jpeg https://axolbio.com/u-s-subsidiary-scheduled/ 2022-05-16T12:53:15+00:00 https://axolbio.com/wp-content/uploads/2018/07/ir_attachment_75597.jpeg https://axolbio.com/understanding-the-mechanisms-of-chemotherapy-induced-neuropathic-pain-using-ipsc-derived-sensory-neurons/ 2022-05-16T12:53:30+00:00 https://axolbio.com/wp-content/uploads/2022/04/blog_post_110.jpeg https://axolbio.com/using-human-ipsc-derived-cortical-neurons-for-the-early-prediction-of-neurotoxicity/ 2022-05-16T12:55:21+00:00 https://axolbio.com/wp-content/uploads/2018/03/3Z0A4253.jpg https://axolbio.com/id-pharma-concluded-an-ips-cell-generation-technology-licensing-agreement-with-uk-based-axol-bioscience/ 2022-05-16T13:07:15+00:00 https://axolbio.com/wp-content/uploads/2022/03/video-image.jpeg https://axolbio.com/meso-brain-initiative-receives-e3-3-million-to-replicate-brains-neural-networks-through-3d-nanoprinting/ 2022-05-16T13:07:57+00:00 https://axolbio.com/wp-content/uploads/2022/03/element02.jpeg https://axolbio.com/axol-bioscience-appoints-paul-andrews-to-scientific-advisory-board/ 2022-05-16T13:08:16+00:00 https://axolbio.com/wp-content/uploads/2022/04/3Z0A4467.jpg https://axolbio.com/axol-bioscience-announces-chas-bountra-as-scientific-advisory-board-member/ 2022-05-16T13:08:56+00:00 https://axolbio.com/wp-content/uploads/2022/03/element02.jpeg https://axolbio.com/axol-bioscience-re-locate-to-chesterford-research-park-to-facilitate-future-growth/ 2022-05-16T13:09:05+00:00 https://axolbio.com/wp-content/uploads/2022/03/video-image.jpeg https://axolbio.com/horizon-discovery-group-plc-and-axol-bioscience-ltd-announce-strategic-partnership/ 2022-05-16T13:09:09+00:00 https://axolbio.com/wp-content/uploads/2022/04/ir_attachment_63176.jpeg https://axolbio.com/axol-bioscience-raises-3-2-million-gbp-c-4-2-million-usd/ 2022-05-19T11:08:47+00:00 https://axolbio.com/wp-content/uploads/2022/03/video-image.jpeg https://axolbio.com/guest-post-astrocytes-in-rett-syndrome-why-we-shouldnt-ignore-them/ 2022-06-27T11:35:12+00:00 https://axolbio.com/wp-content/uploads/2022/04/3Z0A4368.jpg https://axolbio.com/astrocytes-characteristics-and-function-in-development-and-disease/ 2022-07-02T06:49:26+00:00 https://axolbio.com/wp-content/uploads/2022/04/Stem-Cell-Differentiation-1.jpeg https://axolbio.com/expert-tips-on-culturing-human-ipsc-derived-sensory-neurons-to-aid-your-research/ 2022-07-03T06:28:00+00:00 https://axolbio.com/wp-content/uploads/2019/05/A-sit-down-with-Steve-Rees-the-importance-of-understanding-renal-toxicity-in-drug-development.jpeg https://axolbio.com/why-make-the-switch-from-animal-cells-to-human-ipsc-derived-sensory-neurons/ 2022-07-03T06:33:08+00:00 https://axolbio.com/wp-content/uploads/2022/03/blog-banner.jpeg https://axolbio.com/high-throughput-human-model-of-alzheimers-disease-in-a-dish/ 2022-07-11T10:51:03+00:00 https://axolbio.com/wp-content/uploads/2022/04/Alzheimers-Disease_Banner.jpg https://axolbio.com/overcoming-challenges-in-the-stem-cell-ipsc-field/ 2022-07-12T13:10:46+00:00 https://axolbio.com/wp-content/uploads/2022/07/ISSCR.png https://axolbio.com/axol-bioscience-introduces-steve-rees-as-scientific-advisory-board-member-at-slas-2016/ 2022-10-25T21:01:18+00:00 https://axolbio.com/wp-content/uploads/2022/03/video-image.jpeg https://axolbio.com/webinar-cipa-validation-of-hipsc-derived-cardiomyocytes-for-drug-safety-evaluation/ 2022-11-29T18:25:58+00:00 https://axolbio.com/wp-content/uploads/2022/05/blog-banner.webp https://axolbio.com/axol-bioscience-introduces-cipa-validated-human-stem-cell-derived-ventricular-cardiomyocytes-to-help-improve-drug-discovery/ 2023-01-04T14:16:56+00:00 https://axolbio.com/wp-content/uploads/2022/06/ir_attachment_26807-1.webp https://axolbio.com/axol-human-ipsc-derived-interneurons-for-in-vitro-co-culture/ 2023-03-26T11:19:09+00:00 https://axolbio.com/wp-content/uploads/2023/03/interneuron-blog-jpg.jpg https://axolbio.com/celebrating-world-organoid-research-day-2023/ 2023-03-26T11:25:35+00:00 https://axolbio.com/wp-content/uploads/2023/03/organoid.png https://axolbio.com/cardiomyocytes-from-human-ipscs-are-valuable-tools-to-assess-non-clinical-cardiotoxicity/ 2023-04-19T11:32:17+00:00 https://axolbio.com/wp-content/uploads/2022/05/2.png https://axolbio.com/axocellstm-cortical-inhibitory-interneurons/ 2023-04-25T10:00:48+00:00 https://axolbio.com/wp-content/uploads/2023/04/Interneurons-blog-image-.jpg https://axolbio.com/axol-team-leader-presents-at-global-als-conference/ 2023-06-14T11:01:15+00:00 https://axolbio.com/wp-content/uploads/2023/05/WEBSITE-5.jpg https://axolbio.com/crick-institute-and-axol-bioscience/ 2023-06-21T09:59:29+00:00 https://axolbio.com/wp-content/uploads/2023/04/30-off-offer-Email-operations@axolbio.com-for-a-quotation.-Offer-valid-until-30th-June-2023.jpg https://axolbio.com/wp-content/uploads/2023/04/CRICK_Primary_Logo_CMYK-High-res-275x300.jpg https://axolbio.com/demonstrating-physiological-and-pharmacological-relevance-of-axocells-atrial-cardiomyocytes/ 2023-06-26T07:00:11+00:00 https://axolbio.com/wp-content/uploads/2023/06/WEBSITE-8.jpg https://axolbio.com/wp-content/uploads/2023/06/WEBSITE-10.jpg https://axolbio.com/upcoming-webinar-powering-multi-platform-applications-with-axocellstm-motor-neurons/ 2023-06-22T14:42:43+00:00 https://axolbio.com/wp-content/uploads/2023/05/Motor-Neuron-Maturation-Accelerator_ICC.jpg https://axolbio.com/our-stratastem-agreement-using-ipscs-for-alzheimers-drug-discovery/ 2023-06-22T14:43:25+00:00 https://axolbio.com/wp-content/uploads/2022/04/alzheimers-research.jpg https://axolbio.com/moving-towards-in-vitro-from-a-regulatory-perspective-considerations-from-the-fda-modernization-act-2-0/ 2023-06-23T08:39:53+00:00 https://axolbio.com/wp-content/uploads/2023/06/Simon-Hoffman-1.webp https://axolbio.com/wp-content/uploads/2023/05/Ventricular-Cardiomyocytes.jpg https://axolbio.com/wp-content/uploads/2022/11/co-culture-1.png https://axolbio.com/sensory-neurons-that-behave-like-sensory-neurons/ 2023-07-03T13:46:10+00:00 https://axolbio.com/wp-content/uploads/2022/03/x_product_image_68943.png https://axolbio.com/an-important-biological-paradox-that-may-hold-the-key-to-understanding-age-related-diseases-such-as-neurodegeneration/ 2023-07-10T21:26:22+00:00 https://axolbio.com/wp-content/uploads/2022/03/service-image03.jpeg https://axolbio.com/axol-bioscience-launch-human-ipsc-derived-atrial-cardiomyocytes/ 2023-07-11T08:22:47+00:00 https://axolbio.com/wp-content/uploads/2022/03/blog-banner.jpeg https://axolbio.com/axol-bioscience-launches-ipsc-derived-astrocyte-kits/ 2023-07-11T09:45:31+00:00 https://axolbio.com/wp-content/uploads/2022/04/ir_attachment_38571.webp https://axolbio.com/axol-science-scholarship-recipient-vindicating-the-cells-that-make-us-human/ 2023-07-11T10:16:38+00:00 https://axolbio.com/wp-content/uploads/2022/04/The-rise-of-hiPSC-Derived-Motor-Neurons-as-a-physiologically-relevant-model-for-drug-discovery.jpeg https://axolbio.com/human-ipsc-derived-cardiomyocytes-studying-cardiomyocytes-in-vitro/ 2023-07-11T11:13:01+00:00 https://axolbio.com/wp-content/uploads/2022/04/ir_attachment_63176.jpeg https://axolbio.com/human-ipsc-derived-motor-neurons-expert-tips-on-best-cell-culture-practices-to-enhance-your-research/ 2023-07-11T11:25:22+00:00 https://axolbio.com/wp-content/uploads/2018/02/3Z0A4456.jpg https://axolbio.com/wp-content/uploads/2022/07/ir_attachment_68148.png https://axolbio.com/wp-content/uploads/2022/07/1.png https://axolbio.com/wp-content/uploads/2022/07/2.png https://axolbio.com/wp-content/uploads/2022/07/1-1.png https://axolbio.com/wp-content/uploads/2022/07/3.png https://axolbio.com/introduction-of-mea-screening-services-for-human-ipsc-derived-cells/ 2023-07-11T11:41:48+00:00 https://axolbio.com/wp-content/uploads/2022/04/3Z0A4231-1.jpg https://axolbio.com/layers-of-complexity-differentiating-ipscs-into-derivatives-of-the-embryonic-germ-layers/ 2023-07-11T12:46:24+00:00 https://axolbio.com/wp-content/uploads/2022/04/blog_post_110.jpeg https://axolbio.com/reprogramming-somatic-cells-to-induced-pluripotent-stem-cells-ipsc-a-cellular-career-change/ 2023-07-11T13:22:23+00:00 https://axolbio.com/wp-content/uploads/2022/04/ir_attachment_63176.jpeg https://axolbio.com/axol-bioscience-and-metrion-biosciences-announce-research-collaboration/ 2023-07-11T19:30:03+00:00 https://axolbio.com/wp-content/uploads/2022/04/blog_post_110.jpeg https://axolbio.com/a-suffering-relationship-in-alzheimers-disease/ 2023-07-11T19:54:15+00:00 https://axolbio.com/wp-content/uploads/2022/04/A-suffering-relationship-in-Alzheimers-disease.jpeg https://axolbio.com/ipsc-derived-atrial-cardiomyocytes-a-reproducible-platform-for-translational-disease-insights/ 2023-07-11T21:02:34+00:00 https://axolbio.com/wp-content/uploads/2022/04/3Z0A4594.jpg https://axolbio.com/wp-content/uploads/2022/07/1-3.png https://axolbio.com/wp-content/uploads/2022/07/2-2.png https://axolbio.com/wp-content/uploads/2022/07/3-3.png https://axolbio.com/society-of-toxicology-sot-2018/ 2023-07-12T08:32:57+00:00 https://axolbio.com/wp-content/uploads/2022/04/blog-banner_edit.jpg https://axolbio.com/using-hipsc-derived-renal-proximal-tubular-cells-in-vitro-assays-to-advance-disease-research-and-drug-development/ 2023-07-12T08:35:06+00:00 https://axolbio.com/wp-content/uploads/2022/04/Stem-Cell-Differentiation.webp https://axolbio.com/the-rise-of-hipsc-derived-motor-neurons-as-a-physiologically-relevant-model-for-drug-discovery/ 2023-07-12T11:23:49+00:00 https://axolbio.com/wp-content/uploads/2022/04/3Z0A4418.jpg https://axolbio.com/three-reasons-why-ipsc-derived-atrial-cardiomyocytes-are-poised-to-accelerate-atrial-fibrillation-research/ 2023-07-12T11:27:22+00:00 https://axolbio.com/wp-content/uploads/2018/10/blog_post_111.jpeg https://axolbio.com/tracing-the-journey-of-monocytes-to-macrophages-what-does-it-mean-for-your-research/ 2023-07-12T11:32:54+00:00 https://axolbio.com/wp-content/uploads/2022/03/blog-inner-banner.jpeg https://axolbio.com/using-human-ipsc-derived-renal-cells-to-enhance-safety-toxicity-testing-during-drug-development/ 2023-07-12T11:39:20+00:00 https://axolbio.com/wp-content/uploads/2022/04/Stem-Cell-Differentiation-1.jpeg https://axolbio.com/your-stem-cells-are-getting-refreshed-our-updated-product-lines/ 2023-07-12T11:41:18+00:00 https://axolbio.com/wp-content/uploads/2023/03/Untitled-design-7.png https://axolbio.com/axol-demonstrates-excellent-compliance-with-the-isscr-standards-document-2023/ 2023-07-17T19:51:30+00:00 https://axolbio.com/wp-content/uploads/2023/06/WEBSITE-3.jpg https://axolbio.com/perspectives-on-the-fda-modernization-act-2-0-and-drug-discovery-from-elizabeth-baker-esq/ 2023-07-18T07:47:01+00:00 https://axolbio.com/wp-content/uploads/2023/07/WEBSITE-11.jpg https://axolbio.com/upcoming-webinar-using-the-power-of-ipscs-for-patient-stratification/ 2023-07-18T14:53:32+00:00 https://axolbio.com/wp-content/uploads/2023/03/Roslin-2023-Hi-res-photos-27-scaled.jpeg https://axolbio.com/5-key-takeaways-from-not-just-another-nams-meeting-2023/ 2023-07-19T15:04:44+00:00 https://axolbio.com/wp-content/uploads/2023/07/Not-Just-Another-NAMs-Meeting.jpg https://axolbio.com/axol-ceo-summer-review-jan-jun-2023/ 2023-07-31T12:06:25+00:00 https://axolbio.com/wp-content/uploads/2023/07/Liam-Taylor300-scaled-e1690552439498.jpg https://axolbio.com/stepping-up-in-drug-development-moving-from-primary-cells-to-human-ipscs/ 2023-09-07T08:00:54+00:00 https://axolbio.com/wp-content/uploads/2023/06/MEA-Multi-Electrode-Array-axoServices.jpg https://axolbio.com/i-have-a-simple-request-for-you-all-hurry-up-stephen-brannan/ 2023-09-07T10:59:52+00:00 https://axolbio.com/wp-content/uploads/2023/03/brannan.jpg https://axolbio.com/five-key-takeaways-from-the-mps-world-summit-2023/ 2023-09-08T15:43:35+00:00 https://axolbio.com/wp-content/uploads/2022/11/co-culture-1.png https://axolbio.com/netri-launch-new-organ-on-chip-kit-powered-by-axocells/ 2023-09-20T14:02:15+00:00 https://axolbio.com/wp-content/uploads/2023/09/Netri-launches-microfluidics-platform-kits-powered-by-axoCells.jpg https://axolbio.com/ushio-inc-selects-axol-bioscience-as-its-critical-quality-supplier-of-ipsc-derived-sensory-neuron-cells/ 2023-10-24T09:21:39+00:00 https://axolbio.com/wp-content/uploads/2023/09/WEBSITE-2.jpg https://axolbio.com/sygnature-discovery-collaborates-with-axol-bioscience-to-utilize-human-ipsc-derived-microglial-cells-in-high-content-imaging-drug-discovery-screening-workflows/ 2023-10-24T09:21:42+00:00 https://axolbio.com/wp-content/uploads/2023/10/Axol-x-Sygnature-.jpg https://axolbio.com/axol-biosciences-ongoing-commitment-to-support-pharmaceutical-companies-in-japan-with-ipsc-excellence/ 2023-11-01T00:00:52+00:00 https://axolbio.com/wp-content/uploads/2023/10/MicrosoftTeams-image-11-e1698758851793.jpg https://axolbio.com/wp-content/uploads/2023/10/Cosmo-bio.jpg https://axolbio.com/axol-bioscience-will-be-presenting-a-key-new-poster-written-in-partnership-with-sumitomo-pharma-america-inc-at-neuroscience-2023-washington-d-c/ 2023-11-08T08:00:47+00:00 https://axolbio.com/wp-content/uploads/2023/11/Axol-will-be-presenting-a-key-new-poster-written-in-partnership-with-Sumitomo-Pharma-America-Inc.-at-Neuroscience-2023.jpg https://axolbio.com/axol-ceo-end-of-year-review-2023/ 2023-11-29T13:04:50+00:00 https://axolbio.com/wp-content/uploads/2023/07/Liam-Taylor300-scaled-e1690552439498.jpg https://axolbio.com/our-pledge-to-the-ipsc-market/ 2023-12-04T12:14:47+00:00 https://axolbio.com/wp-content/uploads/2023/11/Axol-Bioscience-End-of-the-Year-Review.jpg https://axolbio.com/supporting-the-ipsc-market-with-our-2024-pricing-and-promotions/ 2024-01-02T10:18:11+00:00 https://axolbio.com/wp-content/uploads/2023/12/Shipping-over-Christmas-December-2023.jpg https://axolbio.com/axol-bioscience-signs-product-supply-agreement-with-netri/ 2024-02-01T15:56:20+00:00 https://axolbio.com/wp-content/uploads/2023/09/Netri-launches-microfluidics-platform-kits-powered-by-axoCells.jpg https://axolbio.com/axol-cso-discusses-the-value-of-ipscs-for-patient-stratification/ 2024-02-12T09:45:23+00:00 https://axolbio.com/wp-content/uploads/2022/04/alzheimers-research.jpg https://axolbio.com/unlocking-ipsc-technology-for-better-in-vitro-huntingtons-disease-models/ 2024-03-05T09:47:49+00:00 https://axolbio.com/wp-content/uploads/2023/11/Axol-Bioscience-End-of-the-Year-Review.jpg https://axolbio.com/new-product-launch-axocells-atrial-cardiomyocyte-kit-for-better-arrhythmia-and-cardiotoxicity-modeling/ 2024-03-11T09:52:15+00:00 https://axolbio.com/wp-content/uploads/2024/03/Atrial-Cardiomyocytes-Kit-Axol-Bioscience-Directory.png https://axolbio.com/enhancing-in-vitro-cardiotoxicity-models-with-human-ipsc-technology/ 2024-03-18T13:43:41+00:00 https://axolbio.com/wp-content/uploads/2024/03/Enhancing-in-vitro-cardiotoxicity-models-with-human-iPSC-technology-1.jpg https://axolbio.com/key-takeaways-from-sot-2024/ 2024-03-28T14:37:23+00:00 https://axolbio.com/wp-content/uploads/2024/03/Key-takeaways-from-SOT-2024-1.jpg https://axolbio.com/unlocking-insights-into-sporadic-alzheimers-disease-with-human-ipscs/ 2024-04-04T10:11:59+00:00 https://axolbio.com/wp-content/uploads/2024/04/Unlocking-insights-into-sporadic-AD-with-human-iPSCs-1.jpg https://axolbio.com/axol-bioscience-presented-with-outstanding-workplace-award-2024/ 2024-05-23T15:00:18+00:00 https://axolbio.com/wp-content/uploads/2024/05/Outstanding-Workplace-Award-6.jpg https://axolbio.com/new-product-launch-new-line-lower-price-axocellstm-astrocytes-for-better-neurodegenerative-disease-modeling/ 2024-05-29T08:56:27+00:00 https://axolbio.com/wp-content/uploads/2024/05/New-product-launch-new-line-lower-price-axoCellsTM-Astrocytes-for-better-neurodegenerative-disease-modeling-2.jpg https://axolbio.com/axol-ceo-summer-review-jan-jun-2024/ 2024-07-10T08:10:06+00:00 https://axolbio.com/wp-content/uploads/2024/07/CEO-SUmmer-Review-Liam-Taylor.jpg https://axolbio.com/interview-between-duncan-borthwick-ph-d-and-jiro-kawada-ph-d-co-ceo-jiksak-bioengineering/ 2024-07-30T10:28:42+00:00 https://axolbio.com/wp-content/uploads/2024/07/Interview-between-Duncan-Borthwick-and-Jiro-Kawada-Ph.D.-Co-CEO-Jiksak-Bioengineering.jpg https://axolbio.com/human-ipscs-valuable-models-for-cardiotoxicity-screening/ 2024-08-13T08:40:52+00:00 https://axolbio.com/wp-content/uploads/2023/05/Ventricular-Cardiomyocytes.jpg https://axolbio.com/nectar-2022-in-three-minutes/ 2024-08-13T08:45:36+00:00 https://axolbio.com/wp-content/uploads/2022/12/nectar.png https://axolbio.com/axol-launches-axocells-tm-als-toolbox/ 2024-09-24T14:01:42+00:00 https://axolbio.com/wp-content/uploads/2024/09/axoCells-ALS-Toolbox-Brochure-and-Characterization-Pack.png https://axolbio.com/high-throughput-automated-screening-with-ipsc-derived-microglia-cells-sygnature-discovery-launches-scanme-a-new-high-throughput-platform-for-neuroinflammatory-disease-drug-discovery/ 2024-10-15T10:56:30+00:00 https://axolbio.com/wp-content/uploads/2024/10/SCANME.png https://axolbio.com/axol-bioscience-acquires-phenocell-to-advance-human-disease-models/ 2024-10-21T13:13:16+00:00 https://axolbio.com/wp-content/uploads/2024/10/Axol-Bioscience-acquires-Phenocell-to-advance-human-disease-models-.jpg https://axolbio.com/guest-post-are-3d-neural-cell-cultures-the-best-translational-models-towards-finding-a-cure-for-alzheimers-disease/ 2024-11-27T15:03:52+00:00 https://axolbio.com/wp-content/uploads/2022/04/A-suffering-relationship-in-Alzheimers-disease.jpeg https://axolbio.com/tessara-therapeutics-collaborate-with-axol-bioscience-to-develop-ipsc-derived-3d-human-brain-micro-tissues-for-drug-discovery-applications/ 2024-12-03T08:00:20+00:00 https://axolbio.com/wp-content/uploads/2024/11/Tessara-Therapeutics-collaborate-with-Axol-Bioscience-to-develop-iPSC-derived-3D-human-brain-micro-tissues-for-drug-discovery-applications-1.png https://axolbio.com/phenocell-and-amarna-therapeutics-awarded-eurostars-grant-to-assess-a-gene-therapy-for-dry-amd-using-a-novel-3-dimensional-ipsc-derived-retinal-model-of-the-disease/ 2024-12-11T14:03:56+00:00 https://axolbio.com/wp-content/uploads/2024/12/Phenocell-and-Amarna-Therapeutics-Awarded-Eurostars-Grant-to-Assess-a-Gene-Therapy-for-Dry-AMD-using-a-novel-3-dimensional-iPSC-derived-Retinal-Model-of-the-Disease.jpg https://axolbio.com/ceo-end-of-year-review-2024-a-year-of-ipsc-innovation-and-market-expansion/ 2024-12-19T16:25:38+00:00 https://axolbio.com/wp-content/uploads/2024/12/Liam-Taylor-scaled-e1734624867232.jpg https://axolbio.com/axol-bioscience-secures-the-scottish-smart-grant-to-accelerate-the-development-of-a-commercial-ipsc-powered-als-models/ 2024-12-23T11:31:31+00:00 https://axolbio.com/wp-content/uploads/2024/12/Axol-Bioscience-secures-the-Scottish-SMART-Grant-to-accelerate%E2%80%AFthe-development-of-a-commercial-iPSC-powered-ALS-models.jpg https://axolbio.com/exploring-apoe4-in-ipsc-based-alzheimers-disease-models/ 2025-01-08T14:23:01+00:00 https://axolbio.com/wp-content/uploads/2024/06/Exploring-APOE4-in-iPSC-based-AD-models.jpg https://axolbio.com/unlocking-the-potential-of-ipsc-derived-cell-model-through-large-scale-manufacturing/ 2025-01-10T12:12:16+00:00 https://axolbio.com/wp-content/uploads/2025/01/Unlocking-the-potential-of-iPSC-derived-cell-model-through-large-scale-manufacturing.jpg https://axolbio.com/collaboration-quality-advancing-neuro-disease-models-through-custom-manufacturing-of-ipsc-derived-cells/ 2025-02-13T08:00:57+00:00 https://axolbio.com/wp-content/uploads/2025/02/Collaboration-Quality-Advancing-Neuro-Disease-Models-through-Custom-Manufacturing-of-iPSC-derived-cells.jpg https://axolbio.com/a-deep-dive-into-dry-amd-research-using-ipscs-interview-with-florian-regent-from-axol-bioscience/ 2025-02-17T13:00:32+00:00 https://axolbio.com/wp-content/uploads/2025/02/A-Deep-Dive-into-Dry-AMD-Research-using-iPSCs-Interview-with-Florian-Regent-from-Axol-Bioscience.jpg https://axolbio.com/new-axol-bioscience-antibody-staining-guide/ 2025-03-11T09:26:37+00:00 https://axolbio.com/wp-content/uploads/2025/03/2025-Antibody-Staining-Guide.jpg https://axolbio.com/axol-bioscience-and-stratastem-launch-novel-ipsc-collection-to-advance-alzheimers-disease-research/ 2025-03-14T12:09:32+00:00 https://axolbio.com/wp-content/uploads/2025/02/Axol-Bioscience-and-StrataStem-Launch-Novel-iPSC-Collection-to-Advance-Alzheimers-Disease-Research-.jpg https://axolbio.com/new-partnership-looks-to-improve-cell-reprogramming-methods-for-healthcare-benefits/ 2025-03-26T12:03:39+00:00 https://axolbio.com/wp-content/uploads/2025/03/New-partnership-looks-to-improve-cell-reprogramming-methods-for-healthcare-benefits-1.jpg https://axolbio.com/moving-on-from-primary-cells-the-rise-of-ipsc-fueled-in-vitro-models-in-dermatology-and-cosmetics/ 2025-03-28T12:16:40+00:00 https://axolbio.com/wp-content/uploads/2025/03/Moving-on-from-primary-cells.-The-rise-of-iPSC-fueled-in-vitro-models-in-dermatology-and-cosmetics.jpg https://axolbio.com/custom-manufacturing-of-ipsc-derived-microglia-to-advance-neurodegeneration-disease-models/ 2025-04-08T14:06:05+00:00 https://axolbio.com/wp-content/uploads/2025/04/Custom-Manufacturing-of-iPSC-Derived-Microglia-to-Advance-Neurodegeneration-Disease-Models.jpg https://axolbio.com/large-scale-manufacturing-options-for-human-ipsc-derived-retinal-pigment-epithelium-rpe-cells/ 2025-05-21T13:10:00+00:00 https://axolbio.com/wp-content/uploads/2025/05/Large-Scale-Manufacturing-Options-for-Human-IPSC-Derived-Retinal-Pigment-Epithelium-RPE-Cells-1.jpg https://axolbio.com/axol-biosciences-ipsc-derived-manufacturing-capabilities/ 2025-06-09T12:18:09+00:00 https://axolbio.com/wp-content/uploads/2025/06/Axol-Biosciences-iPSC-derived-manufacturing-capabilities-1.jpg https://axolbio.com/axol-bioscience-ipscs-and-microphysiological-systems-mps-tech-journal-2025/ 2025-06-11T13:15:56+00:00 https://axolbio.com/wp-content/uploads/2025/06/Axol-Bioscience-iPSCs-and-Microphysiological-Systems-MPS-%E2%80%93-Tech-Journal-2025-2.jpg https://axolbio.com/introducing-the-new-axocells-sensory-neurons-v2-0-xeno-free-xf-bundle-kits/ 2025-06-16T13:06:56+00:00 https://axolbio.com/wp-content/uploads/2025/01/Introducing-the-new-axoCellsTM-Sensory-Neurons-V2.0-Xeno-Free-XF-Bundle-Kits-2.jpg https://axolbio.com/als-tdi-announces-new-agreement-with-axol-bioscience-to-expand-access-to-als-patient-ipsc-derived-cells-for-global-research/ 2025-06-24T12:47:31+00:00 https://axolbio.com/wp-content/uploads/2025/06/ALS-TDI-Announces-New-Agreement-with-Axol-Bioscience-.png https://axolbio.com/axol-bioscience-ceo-summer-review-2025/ 2025-06-26T14:55:44+00:00 https://axolbio.com/wp-content/uploads/2025/06/Axol-Bioscience-CEO-Summer-Review-2025.jpg https://axolbio.com/phenocell-axol-a-story-of-a-successful-acquisition-and-integration-process/ 2025-07-09T07:23:14+00:00 https://axolbio.com/wp-content/uploads/2025/07/Phenocell-Axol-a-story-of-a-successful-acquisition-and-integration-process.-1.jpg https://axolbio.com/catherine-elton-joins-axol-bioscience-as-chief-business-officer/ 2025-07-24T14:29:56+00:00 https://axolbio.com/wp-content/uploads/2025/07/Catherine-Elton-joins-Axol-Bioscience-as-Chief-Business-Officer.jpg https://axolbio.com/the-future-of-basement-membrane-matrices-for-ipsc-cell-culture/ 2025-09-05T08:05:55+00:00 https://axolbio.com/wp-content/uploads/2025/09/The-future-of-basement-membrane-matrices-for-iPSC-cell-culture-.jpg https://axolbio.com/axol-bioscience-expands-ipsc-library-to-accelerate-ophthalmology-research/ 2025-09-09T07:56:14+00:00 https://axolbio.com/wp-content/uploads/2025/09/Axol-Bioscience-Expands-iPSC-Library-to-Accelerate-Ophthalmology-Research-1.jpg https://axolbio.com/modeling-the-genomic-instability-of-huntingtons-disease-with-ipsc-technology/ 2025-11-05T08:00:55+00:00 https://axolbio.com/wp-content/uploads/2025/11/Modeling-the-genomic-instability-of-Huntingtons-Disease-with-iPSC-technology-1.jpg https://axolbio.com/frequently-asked-questions-for-neurological-immune-cells/ 2025-12-09T08:22:25+00:00 https://axolbio.com/wp-content/uploads/2024/08/Jessica-Tillman-Microglia-FAQ.jpg https://axolbio.com/new-myomaxtm-media-enhances-ipsc-derived-cardiomyocyte-maturity-for-superior-in-vitro-cardiac-models/ 2025-12-11T12:38:21+00:00 https://axolbio.com/wp-content/uploads/2025/03/MyoMax-2.jpg https://axolbio.com/a-step-toward-closing-the-translational-gap-in-drug-development/ 2025-12-19T10:20:32+00:00 https://axolbio.com/wp-content/uploads/2025/12/The-future-of-biomedical-research-is-human-based.jpg https://axolbio.com/the-future-of-biomedical-research-is-human-based/ 2025-12-22T14:02:33+00:00 https://axolbio.com/wp-content/uploads/2023/11/Untitled-design.jpg https://axolbio.com/ceo-end-of-year-review-2025-building-better-human-disease-models-for-a-changing-world/ 2025-12-23T08:59:49+00:00 https://axolbio.com/wp-content/uploads/2025/12/CEO-end-of-year-review-2025-building-better-human-disease-models-for-a-changing-world-.jpg https://axolbio.com/axol-bioscience-raises-2-8m-to-advance-us-expansion-and-product-development/ 2026-01-13T15:40:58+00:00 https://axolbio.com/wp-content/uploads/2026/01/Axol-Bioscience-raises-2.8M-to-advance-US-expansion-and-product-development.jpg https://axolbio.com/retinal-organoid-ophthalmology/ 2026-02-27T16:53:05+00:00 https://axolbio.com/wp-content/uploads/2026/02/Figure-1-Retinal-Organoid-e1771408986371.jpg https://axolbio.com/microglia-faq-applications-disease-modeling-organoids-co-cultures-screening-next-gen-advances/ 2026-03-03T17:18:27+00:00 https://axolbio.com/wp-content/uploads/2026/03/iPSC-derived-microglia.png https://axolbio.com/axol-bioscience-joins-quantum-biotechnology-consortium-advancing-alzheimers-research/ 2026-03-04T15:39:50+00:00 https://axolbio.com/wp-content/uploads/2026/03/Axol-Bioscience-joins-quantum-biotechnology-consortium-advancing-Alzheimers-research.jpg https://axolbio.com/prism-als-new-stem-cell-models-could-transform-research-into-treatments-for-mnd-als/ 2026-03-31T13:01:42+00:00 https://axolbio.com/wp-content/uploads/2026/03/Motor-neurons-microglia-and-astrocytes-triculture.png https://axolbio.com/inside-prism-our-ceos-perspective-on-building-the-future-of-als-mnd-research/ 2026-04-01T09:41:22+00:00 https://axolbio.com/wp-content/uploads/2024/12/Liam-Taylor-scaled-e1734624867232.jpg https://axolbio.com/patient-stratification-in-alzheimers-disease-supporting-preclinical-in-vitro-model-building-and-drug-discovery-with-ipscs/ 2026-04-09T07:38:05+00:00 https://axolbio.com/wp-content/uploads/2026/03/Patient-stratification-in-Alzheimers-disease-supporting-preclinical-in-vitro-model-building-and-drug-discovery-with-iPSCs.jpg https://axolbio.com/axol-bioscience-joins-the-british-chambers-of-commerce-trade-accelerator-programme/ 2026-05-19T07:22:20+00:00 https://axolbio.com/wp-content/uploads/2026/05/Axol-Bioscience-joins-the-British-Chambers-of-Commerce-Trade-Accelerator-programme.jpg https://axolbio.com/cellvoyant-and-axol-bioscience-partner-to-advance-ai-guided-imaging-for-cardiomyocyte-manufacturing/ 2026-06-09T09:00:22+00:00 https://axolbio.com/wp-content/uploads/2026/06/CellVoyant-and-Axol-Bioscience-announce-strategic-collaboration-to-advance-AI-guided-predictive-imaging-assays-for-cardiomyocyte-manufacturing-.jpg https://axolbio.com/axol-bioscience-has-been-named-in-the-sunday-times-scotland-fast-50/ 2026-06-26T13:40:17+00:00 https://axolbio.com/wp-content/uploads/2026/06/Axol-Bioscience-has-been-named-in-The-Sunday-Times-Scotland-Fast-50.-1.jpg https://axolbio.com/ceo-summer-review-2026-advancing-translational-research-through-physiologically-relevant-ipsc-derived-models/ 2026-07-16T09:30:56+00:00 https://axolbio.com/wp-content/uploads/2024/12/Liam-Taylor-scaled-e1734624867232.jpg https://axolbio.com/how-our-license-with-the-francis-crick-institute-could-de-risk-drug-development/ 2026-07-24T14:19:04+00:00 https://axolbio.com/wp-content/uploads/2023/04/WEBSITE-1.jpg